The Symplicity HTN-2 trial was an international, multi-center, prospective, randomized, controlled study of the safety and effectiveness of renal denervation in patients with uncontrolled hypertension. One hundred-six patients were enrolled from 24 investigational sites. At baseline the randomized treatment and control patients had similar high blood pressures: 178/97 mmHg and 178/98 mmHg, respectively, despite both receiving an average daily regimen of five antihypertensive medications. After six months, the average blood pressure of the renal denervation group was reduced to 146/85 mmHg, compared to an average blood pressure of 179/98 mmHg for the control group.
The study also found that the therapy was safe, with no serious device or procedure-related events, no cardiovascular complications and no kidney-related complications.
http://www.medgadget.com/archives/2...onal_medical_treatment_in_clinical_trial.html
very interesting concept and the data looks good. perhaps we can help some patients with hypertension?
The study also found that the therapy was safe, with no serious device or procedure-related events, no cardiovascular complications and no kidney-related complications.
http://www.medgadget.com/archives/2...onal_medical_treatment_in_clinical_trial.html
very interesting concept and the data looks good. perhaps we can help some patients with hypertension?
Last edited: